易明医药股东北京福好企业管理合伙企业(有限合伙)质押2192.49万股，占总股本11.5%

Group 1 - The core point of the news is that Beijing Fuhao Enterprise Management Partnership has pledged 21.92 million shares of Yiming Pharmaceutical, accounting for 11.5% of the total share capital, which raises concerns about the financial stability of the company [1] - As of the announcement date, the total pledged shares by Beijing Fuhao Enterprise account for 49.99% of its total holdings [1] - The pledge may impact the perception of Yiming Pharmaceutical's financial health among investors and stakeholders [1] Group 2 - Yiming Pharmaceutical reported a main revenue of 311 million yuan for the first half of 2025, a year-on-year decrease of 11.52% [3] - The net profit attributable to shareholders was 37.56 million yuan, down 5.27% year-on-year, while the non-recurring net profit increased by 102.33% to 25.02 million yuan [3] - In Q2 2025, the company achieved a single-quarter revenue of 163 million yuan, a decline of 14.95%, but the net profit attributable to shareholders rose by 59.73% to 18.76 million yuan [3] - The company has a debt ratio of 23.32% and a gross profit margin of 80.89% [3] Group 3 - Yiming Pharmaceutical's main business includes self-produced pharmaceuticals, third-party cooperative pharmaceuticals, raw materials, and pharmaceutical promotion services [4]